$69.86 +1.28 (%) ISIS Pharmaceuticals Inc - NASDAQ

Jan. 29, 2015 | 04:00 PM

Partner Headlines

  1. Morning Market Losers

    Benzinga | Jan. 14, 2015 | 09:55AM EST
  2. Benzinga's Top #PreMarket Losers

    Benzinga | Jan. 14, 2015 | 08:13AM EST
  3. Cybersecurity Stocks To Watch Following U.S. Central Command Twitter Hack

    Benzinga | Jan. 12, 2015 | 14:40PM EST
  4. Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 1

    Benzinga | Jan. 12, 2015 | 08:55AM EST
  5. Hot Biotech Stocks: Isis, Kite Jump On Big Deals

    IBD | Jan. 5, 2015 | 18:20PM EST
  6. Isis Pharma To Develop GI Drugs With J&J

    IBD | Jan. 5, 2015 | 13:17PM EST
  7. Benzinga's Volume Movers

    Benzinga | Jan. 5, 2015 | 10:38AM EST
  8. Morning Market Movers

    Benzinga | Jan. 5, 2015 | 09:47AM EST
  9. Monday #PreMarket Movers: Conatus Pharmaceuticals, Brainstorm Cell Therapeutics And More

    Benzinga | Jan. 5, 2015 | 09:31AM EST
  10. Gas Price Year In Review: Lowest Levels In 5 Years

    Benzinga | Dec. 31, 2014 | 15:07PM EST
  11. Biotech Stocks Sell Off, ETFs Fall Over 5%

    Benzinga | Dec. 23, 2014 | 14:35PM EST
  12. Worst Performing Industries For December 23, 2014

    Benzinga | Dec. 23, 2014 | 11:25AM EST
  13. Mid-Morning Market Update: Markets Mostly Higher; Walgreen Profit Beats Expectations

    Benzinga | Dec. 23, 2014 | 10:40AM EST
  14. CNBC's Stock Pops & Drops From December 16

    Benzinga | Dec. 17, 2014 | 07:35AM EST
  15. 3 Biotech ETFs Rally On Merger News

    Benzinga | Dec. 8, 2014 | 17:43PM EST
  16. Mid-Afternoon Market Update: Dow Slides Over 100 Points; Oil Futures Down 4%

    Benzinga | Dec. 8, 2014 | 15:37PM EST
  17. Mid-Day Gainers From December 8: Cubist Pharmaceuticals, Acceleron Pharma, Calithera Biosciences, Cempra, Isis Pharmaceuticals

    Benzinga | Dec. 8, 2014 | 13:00PM EST
  18. ISIS-STAT3 Rx And ISIS-AR Rx Data Presented By AstraZeneca At European Cancer Symposium

    Benzinga | Nov. 20, 2014 | 16:48PM EST
  19. Isis Pharmaceuticals Prices Offering of $425M Of 1.00% Convertible Senior Notes

    Benzinga | Nov. 12, 2014 | 07:02AM EST
  20. Earnings Scheduled For November 7, 2014

    Benzinga | Nov. 7, 2014 | 05:13AM EST
  21. NASDAQ Slides 1.2%; Manitowoc Shares Dip Following Cautious Outlook

    Benzinga | Oct. 10, 2014 | 13:20PM EST
  22. Markets Mixed; Fastenal Earnings Meet Estimates

    Benzinga | Oct. 10, 2014 | 11:26AM EST
  23. Morning Market Movers

    Benzinga | Oct. 10, 2014 | 09:37AM EST
  24. Benzinga's Top #PreMarket Gainers

    Benzinga | Oct. 10, 2014 | 08:11AM EST
  25. US Stock Futures Signal Lower Start On Wall Street

    Benzinga | Oct. 10, 2014 | 07:20AM EST
  26. Making Money With Charles Payne: 10/08/14

    FoxBusiness | Oct. 9, 2014 | 18:00PM EST
  27. US Stock Futures Mixed Ahead Of Jobless Claims Data

    Benzinga | Oct. 9, 2014 | 07:26AM EST
  28. Isis Pharmaceuticals Earns $18M From GSK For Advancing ISIS-TTR Rx

    Benzinga | Oct. 9, 2014 | 07:02AM EST
  29. GasBuddy: Lowest Gas Prices Of 2014 Unfolding Right Now

    Benzinga | Oct. 7, 2014 | 13:30PM EST
  30. Brent Remains Below $97 On Weak Chinese Data

    Benzinga | Sep. 29, 2014 | 08:48AM EST
  31. Isis Pharmaceuticals Earns $4M from Achaogen For The Initiation Of A Phase 3 Study Of Plazomicin

    Benzinga | Sep. 17, 2014 | 07:27AM EST
  32. Making Money With Charles Payne: 08/29/14

    FoxBusiness | Sep. 3, 2014 | 10:33AM EST
  33. Tensions & Airlines Boost ETFs (ITA, PPA, BA, LMT)

    Benzinga | Aug. 27, 2014 | 15:46PM EST
  34. Companies With 'ISIS' Name Get Unwanted Attention

    FoxBusiness | Aug. 27, 2014 | 15:06PM EST
  35. Isis Pharmaceuticals Finally Breaks Out

    Benzinga | Aug. 27, 2014 | 12:30PM EST
  36. CNBC's Stock Pops & Drops From August 26

    Benzinga | Aug. 26, 2014 | 20:16PM EST
  37. Winners & Losers From Tuesday, August 26

    Benzinga | Aug. 26, 2014 | 16:02PM EST
  38. Fast Money Picks For August 26

    Benzinga | Aug. 25, 2014 | 20:03PM EST
  39. US Stock Futures Up Ahead Of Economic Data

    Benzinga | Aug. 15, 2014 | 07:50AM EST
  40. UPDATE: Laidlow & Co. Initiates Coverage on Isis Pharmaceuticals, Inc. at Buy, Announces $52.00 PT

    Benzinga | Aug. 12, 2014 | 11:34AM EST
  41. Isis Pharmaceuticals Initiates Phase 2 Study Of ISIS-APO(a) Rx In Patients With High Lp(a)

    Benzinga | Jul. 17, 2014 | 07:01AM EST
  42. Markets Edge Higher; Alcoa Profit Beats Street View

    Benzinga | Jul. 9, 2014 | 10:20AM EST
  43. US Stock Futures Edge Higher Ahead Of ADP Report

    Benzinga | Jul. 2, 2014 | 07:36AM EST
  44. Isis Pharmaceuticals Earns $1M From GSK For Advancing Hepatitis B Virus Program

    Benzinga | Jul. 2, 2014 | 07:00AM EST
  45. Benzinga's Top #PreMarket Losers

    Benzinga | Jun. 27, 2014 | 08:11AM EST
  46. Brent Steady As Iraqi Exports Look Unaffected

    Benzinga | Jun. 26, 2014 | 09:24AM EST
  47. Brent Retreats As Supply Interruption Worries Fade

    Benzinga | Jun. 24, 2014 | 09:34AM EST
  48. Brent Up To $115 As ISIS Moves Toward Baghdad

    Benzinga | Jun. 23, 2014 | 09:10AM EST
  49. Brent Climbs As Iraqi Oil Supplies Are Threatened

    Benzinga | Jun. 20, 2014 | 08:10AM EST
  50. ISIS Pharma Trades Up Premarket; NYT Says Has Potential Heart Attack Drug

    Benzinga | Jun. 19, 2014 | 10:27AM EST
Trading Center